Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058357 · ClinicalTrials.gov registry record · Phase 3
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00058357 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 30 participants.
The verdict
NCT00058357, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
RATIONALE: A lidocaine patch may be effective in relieving numbness, tingling, and other symptoms of neuropathy. It is not yet known whether a lidocaine patch is effective in treating neuropathy in patients who have undergone surgery for cancer. PURPOSE: This randomized phase III trial is studying lidocaine patch to see how well it works compared to a placebo patch in relieving numbness, tingling, and other symptoms of neuropathy in patients who have undergone surgery for cancer.
Interventions
- OTHER placebo
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-05 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00058357
The ClinicalTrials.gov registry entry for NCT00058357 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00058357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00058357 about?
NCT00058357 is a clinical study titled "Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery". RATIONALE: A lidocaine patch may be effective in relieving numbness, tingling, and other symptoms of neuropathy. It is not yet known whether a lidocaine patch is effective in treating neuropathy in patients who have undergone surgery for cancer. PURPOSE: This randomized phase III trial is studying ...
What is the current status of trial NCT00058357?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2004-05. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00058357?
The interventions under investigation include: placebo (OTHER), lidocaine (DRUG).
Who is sponsoring clinical trial NCT00058357?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.